Tilray Australia is a subsidiary of Tilray, a Canadian medical cannabis company. Tilray was founded in 2013 and was the first company to legally export medical cannabis from Canada to Australia. Tilray’s cannabis is produced at their $26 million cultivation facility, which is located in Nanaimo, Canada. 

Tilray Australia is a GMP-certified supplier of medical cannabis products, with their most popular products including their range of THC and CBD oils. The company is also heavily involved in research, partnering with the University of Sydney, Chris O’Brien Lifehouse, and the NSW Government in a clinical trial on chemotherapy-induced nausea and vomiting in 2016. 

Tilray now operates out of Toronto, NewZealand, Germany, Latin America and Portugal. The company employs over 130 people worldwide. Tilray is also publicly listed on the NASDAQ as TLRY in 2018.